Transcriptional regulation of metabolic and inflammatory genes

Transcriptional regulation of metabolic and inflammatory genes is a complex biological process involving the coordinated action of various transcription factors and coregulators to maintain cellular and systemic homeostasis. This process is primarily mediated by members of the nuclear receptor superfamily, such as Peroxisome Proliferator-Activated Receptors (PPARs), Liver X Receptors (LXRs), and the Glucocorticoid Receptor (GR), which serve as sensors for metabolic intermediates and signaling molecules (Glass & Ogawa, 2006, Nature Reviews Immunology). These receptors bind to specific DNA sequences to either activate or repress the expression of genes involved in lipid metabolism, glucose disposal, and the production of inflammatory mediators like cytokines and chemokines (Ricote & Glass, 2007, Nature). Dysregulation of these transcriptional networks is a key driver in the development of chronic metabolic diseases, including type 2 diabetes, obesity, and atherosclerosis, where metabolic dysfunction is coupled with persistent low-grade inflammation (Desvergne et al., 2006, Physiological Reviews). Therapeutic intervention often involves the use of synthetic ligands, such as thiazolidinediones or fibrates, which target specific receptors within this process to improve insulin sensitivity or lipid profiles while simultaneously exerting anti-inflammatory effects. Because this entry refers to a broad biological mechanism rather than a single molecular entity, it is classified as a process rather than a specific therapeutic target.

Other names

Metabolic and inflammatory gene regulationTranscriptional control of metabolism and inflammationNuclear receptor-mediated metabolic-inflammatory crosstalk

Modulation of nuclear receptor activity (e.g., PPARs, LXRs, GR) to alter the expression of genes involved in metabolic pathways and inflammatory signaling.